Related Experiment Videos
Molecular detection of hepatitis C virus: impact of detection methodology on clinical and laboratory correlations
1Department of Microbiology, Toronto Hospital, Ontario, Canada.
Insights
Hepatitis C virus (HCV) diagnosis is crucial for managing chronic infections and associated liver diseases. Modern nucleic acid tests offer faster detection of acute HCV infection compared to older serological assays.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis C virus (HCV) infections often present asymptomatically, making them difficult to diagnose clinically.
- HCV is a major cause of parenterally transmitted non-A, non-B hepatitis (NANBH), leading to chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
- While blood screening has reduced transfusion-associated HCV, sporadic infections and chronic disease progression remain significant concerns.
Purpose of the Study:
- To review the impact of modern serologic and nucleic acid-based detection methods on understanding HCV infection.
- To highlight the clinical significance of HCV diagnosis in light of its transmissability and long-term health risks.
- To emphasize the need for advanced detection assays for clinical insights and antiviral efficacy assessment.
Main Methods:
- Review of serological testing for Hepatitis C virus (HCV) antibody.
- Analysis of polymerase chain reaction (PCR)-based detection of HCV RNA in serum.
- Comparison of diagnostic lag times between immunoassays and nucleic acid amplification tests.
Main Results:
- Serological screening significantly reduced transfusion-associated HCV infections.
- HCV diagnosis remains critical due to the high rate of chronic infection and associated risks (cirrhosis, cancer).
- Nucleic acid-based assays (PCR) detect HCV RNA much earlier (1-2 weeks) than immunoassays (10-26 weeks).
Conclusions:
- Modern serologic and nucleic acid-based methods have advanced the clinical understanding of HCV infection, its illnesses, and transmissability.
- Early detection of HCV infection is vital for managing chronic disease and preventing severe liver complications.
- Quantitative and reproducible nucleic acid detection assays are essential for further research and evaluating antiviral treatments.
Abstract:
The clinical manifestations of hepatitis C virus (HCV) infection are generally indistinguishable from other causes of viral hepatitis. HCV infections are usually anicteric, asymptomatic, and rarely cause acute fulminant liver failure. Serological testing for HCV in conjunction with epidemiological studies have verified that HCV was the major cause of parenterally transmitted non-A, non-B hepatitis (NANBH). With the widespread introduction of serological screening of blood products for HCV antibody, the risk of transfusion-associated HCV infection has been dramatically reduced (to < 3 cases per 10,000 units transfused). Despite the virtual elimination of transfusion-associated infections, the diagnosis of HCV remains important because > 50% of infections are sporadic in origin, 50 to 70% of infected individuals develop chronic hepatitis, and these individuals are at risk of developing cirrhosis (> 20%) as well as hepatocellular carcinoma. Although currently available anti-HCV immunoassays function well as blood-donor screening assays, they are poor at detecting acute infection because of the prolonged lag time between infection and detection of seroconversion (approximately 10 to 26 weeks for second-generation immunoassays). In contrast, polymerase chain reaction (PCR)-based detection of HCV RNA in serum can detect infection in as little as 1 to 2 weeks after exposure. This review focuses on the impact of modern serologic and nucleic acid-based HCV detection methodology on the clinical understanding of HCV infection, its associated illnesses, and its transmissability. Quantitative and reproducible nucleic acid-based detection assays will be required to provide additional insights into the clinical spectrum of HCV infections as well as to assess the efficacy of antiviral agents.